SU5416

semaxanib · Sugen, Inc.

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for SU5416, covering 2008-03-04 to 2014-08-29. Get the full timeline:

Most recent: Clinical Trial Update: SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 2]